BridgeBio Pharma, Inc. (BBIO)
NASDAQ·Healthcare·Biotechnology
$69.52
+2.01%
Mkt Cap $13.32B
Analyst Ratings
Buy
20
Hold
2
Sell
0
Price Target (52 analysts)
$110.09
Range $97.00 – $130.00
Implied Upside
+58.4%
Consensus $110.09 vs current $69.52
NASDAQ·Healthcare·Biotechnology
$69.52
+2.01%
Mkt Cap $13.32B
Buy
20
Hold
2
Sell
0
Price Target (52 analysts)
$110.09
Range $97.00 – $130.00
+58.4%
Consensus $110.09 vs current $69.52